- SPANNR
- Posts
- 10/13/22: Issue #22
10/13/22: Issue #22
Issue #22
October 13, 2022 | Issue #22
Good Evening
. Welcome back to another issue of Spannr.
In this week's newsletter
:
👨🚀 Reaching for the stars
🏁 Starting points
💰 September's
busy
month of fundraising
📚 Weekend reading material
One Small Step for Man, One Giant Leap for Longevity?
From the earliest moments of consciousness, humankind looked to the stars for answers.Much as our forefathers used astrotheology as a predictive tool, today, we are harnessing science in conjunction with space to see what's happening beneath the hood of our bodies.While the methods have advanced, our core intent hasn’t. Not satisfied with Earthly bondage, our limitless thirst for knowledge and exploration drives us to the stars. It just so happens that, more recently, we’re finding tools to unlock longevity in that cosmic quest.
New To The Field?
One of the most common questions that the Spannr team gets from people outside of the world of longevity is: Where do I start?For all of you longevity-focused researchers and entrepreneurs on this list, that may seem like a petty question, but to the average, interested person looking to get involved, it's fundamental.Sure, we could suggest "go read the research," but if we are being honest, not only is that a daunting task, but a confusing one.That's because if you don't have a foundation in biology, many of the words used in the research are difficult to understand. And a quick search on Google doesn't really help much either.That's why, over the past few months, Spannr has been quietly building out our glossary of aging and longevity-related terms to help assist those looking to implement longevity strategies into their lives.Spannr's goal is to bridge the gap between longevity's difficult yet important concepts with the average consumer who is sick of reading clickbaity headlines filled with questionable research. The glossary is one of many of these tools we plan on launching in the coming months.Although we have only just started down this journey, we plan on having a simple-to-understand definition for every important longevity term. Here are a few we've published:
Want to contribute?
😎 Give us a shout by replying to this email.
Last month proved to be full of activity, with many exciting companies emerging and/or raising capital in the longevity space.📌 According to our data, $471M was raised across 14 funding rounds.
In case you missed them, in this post we highlighted each of the funding announcements from the month of September and followed up with some notable observations surrounding today’s investment landscape.Continue reading to see who else received fresh funding over the past week. 👇👇
Vita Therapeutics, a cell engineering company harnessing the power of genetics to develop novel cellular therapies to treat muscular dystrophies and cancers, announced the completion of a $31 million Series B financing – with participation from Cambrian BioPharma, Solve FSHD, Riptide Ventures, Cedars Sinai, and TEDCO
Buck Institute Awarded $2.4 Million Grant to Develop Smart Drug Delivery System Targeting Multiple Alzheimer's Pathologies Simultaneously
FOXO Technologies Announces First Distribution Partner and Begins Product Rollout in California; Expands Executive Team With Insurance Industry Talent
Terray Therapeutics, which recently raised $60 million, will partner with Calico to identify novel therapeutics for patients affected by serious diseases of aging
Elysium Health Announces Positive Results on Its Product Basis™ Published in Hepatology
BrainStorm Presents New Biomarker Analyses from NurOwn's Phase 3 ALS Trial at the ALS ONE Research Symposium
‘Our patients aren’t dead’: Inside the cryogenic freezing facility with 199 humans on ice (Metro)
How genes, sex, growth and age impact lifespan (EPFL)
Don’t Mess with Meiosis: Study Suggests How Reproductive Health Influences Overall Health and Aging (UPMC)
Authors’ names have ‘astonishing’ influence on peer reviewers (Nature)
In gold-standard trial, invitation to colonoscopy reduced cancer incidence but not death (STAT)
AI tool can scan your retina and predict your risk of heart disease ‘in 60 seconds or less’ (The Verge)
Ageless, a new film on the biology of aging, debuts trailer (Agelessfilm)
An introduction to Alzheimer's Disease (Nintil)
Thor 🤝 Longevity (YouTube)
Performance:
Latest Price: $133.747d-Return: 2.63%Market Cap: $11.41b
Big Movers: